Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Other Non Operating Income (2020 - 2022)

Historic Other Non Operating Income for Terns Pharmaceuticals (TERN) over the last 3 years, with Q4 2022 value amounting to -$4000.0.

  • Terns Pharmaceuticals' Other Non Operating Income fell 14000.0% to -$4000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was -$68000.0, marking a year-over-year decrease of 27000.0%. This contributed to the annual value of -$11000.0 for FY2024, which is 9649.68% up from last year.
  • As of Q4 2022, Terns Pharmaceuticals' Other Non Operating Income stood at -$4000.0, which was down 14000.0% from -$14000.0 recorded in Q3 2022.
  • In the past 5 years, Terns Pharmaceuticals' Other Non Operating Income registered a high of $10.7 million during Q4 2020, and its lowest value of -$387000.0 during Q3 2020.
  • For the 3-year period, Terns Pharmaceuticals' Other Non Operating Income averaged around $889416.7, with its median value being $4000.0 (2021).
  • Within the past 5 years, the most significant YoY rise in Terns Pharmaceuticals' Other Non Operating Income was 13076.92% (2022), while the steepest drop was 45000.0% (2022).
  • Over the past 3 years, Terns Pharmaceuticals' Other Non Operating Income (Quarter) stood at $10.7 million in 2020, then plummeted by 99.91% to $10000.0 in 2021, then tumbled by 140.0% to -$4000.0 in 2022.
  • Its Other Non Operating Income stands at -$4000.0 for Q4 2022, versus -$14000.0 for Q3 2022 and -$54000.0 for Q2 2022.